Concepedia

Author

Gillian G. Johnson

Royal Liverpool and Broadgreen University Hospital NHS Trust

Also Known As

G G Johnson, Gillian G Johnson, Gillian G. Johnson, Gillian Johnson

19

Publications

453

Citations

9

H-Index

12

Concepts

All Affiliations

Royal Liverpool and Broadgreen University Hospital NHS TrustUniversity of LiverpoolInstitute of Cancer ResearchLiverpool Women's Hospital
GG

About

Gillian G. Johnson is an author at Royal Liverpool and Broadgreen University Hospital NHS Trust specializing in medicine, cancer research, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

113

2

Cell Biology

2

2

113

3

Immunology

2

2

113

4

Pathology

1

1

35

5

Epigenetic Regulation

1

1

35

Gillian G. Johnson

×

9

Publications

449

Citations

9

H-Index

YearCitations

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of <i>TP53</i>: Final Results of the National Cancer Research Institute CLL206 Trial

Andrew R. Pettitt, Richard E. Jackson, Stacey Carruthers,

Journal of Clinical Oncology

2012

164

Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells

Ke Lin, Nichola Rockliffe, Gillian G. Johnson,

Oncogene

2007

78

CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia

Gillian G. Johnson, Ke Lin, Trevor F. Cox,

Blood

2013

41

A Novel Type of p53 Pathway Dysfunction in Chronic Lymphocytic Leukemia Resulting from Two Interacting Single Nucleotide Polymorphisms within the <i>p21</i> Gene

Gillian G. Johnson, Paul D. Sherrington, Anthony Carter,

Cancer Research

2009

40

Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia

Gina Eagle, Jianguo Zhuang, Rosalind E. Jenkins,

Molecular & Cellular Proteomics

2015

36

Loss of <i>MIR15A</i> and <i>MIR16‐1</i> at 13q14 is associated with increased <i>TP53 </i><scp>mRNA</scp>, de‐repression of <i>BCL2</i> and adverse outcome in chronic lymphocytic leukaemia

Ke Lin, Mosavar Farahani, Yi Yang,

British Journal of Haematology

2014

35

Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration

Ke Lin, Janet Adamson, Gillian G. Johnson,

Clinical Cancer Research

2012

34

Selective <scp>IAP</scp> inhibition results in sensitization of unstimulated but not <scp>CD</scp>40‐stimulated chronic lymphocytic leukaemia cells to <scp>TRAIL</scp>‐induced apoptosis

Jianguo Zhuang, Naomi Laing, Melanie Oates,

Pharmacology Research & Perspectives

2014

11

The gene expression signature associated with <i><scp>TP</scp>53</i> mutation/deletion in chronic lymphocytic leukaemia is dominated by the under‐expression of <i><scp>TP</scp>53</i> and other genes on chromosome 17p

Ke Lin, Brian Lane, Anthony Carter,

British Journal of Haematology

2012

10

Page 1